Financial News

Fourth-quarter sales and other revenue reached $17.4 billion during the 12 weeks ended Feb. 26, due to an increase in identical sales and higher fuel sales, with retail price inflation contributing to the identical sales increase.

The company reported strong execution in its business segments led by COVID-19 vaccinations and testing.

Despite reporting a fourth quarter same-store sales decrease of 1.4%, the retailer plans to execute 2,980 real estate projects in the fiscal year 2022.

Shoppers Drug Mart has agreed to acquire Lifemark Health Group for an aggregate cash consideration of $845 million.

CVS Health is seeking to patent its stores and sales of virtual goods, including prescription drugs, wellness, beauty and personal care products in the metaverse, according to a report.

Moving forward Akorn said it will invest in its facilities and targeted avenues of growth, such as its human generics and animal care businesses.

New financial services available to Dollar General shoppers include its exclusive spendwell Financial Bank, buy now and pay later with Sezzle and FIS Worldpay card reward points.

Upon completion of the distribution, Embecta will be an independent and publicly traded company focused on diabetes management that BD will retain no ownership interest.

The sale of Lannett’s liquid drug manufacturing facility in Carmel, N.Y., to a private company, is anticipated to close within the next several weeks.

The wholesaler’s quarterly revenue rose to $51.9 billion.

Target posted 2021 total revenue of $106 billion and 35% growth over the past two years.

The sale reportedly will lead to the dismantling of the Walgreens Boots Alliance, which was set up in 2014 when Walgreens took full control of the health and beauty chain.